000 01614 a2200481 4500
005 20250515151541.0
264 0 _c20090202
008 200902s 0 0 eng d
022 _a1423-0240
024 7 _a10.1159/000165056
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIdelevich, Efraim
245 0 0 _aOverall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience.
_h[electronic resource]
260 _bOnkologie
_cDec 2008
300 _a673-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCisplatin
_xadministration & dosage
650 0 4 _aEsophageal Neoplasms
_xmortality
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aIsrael
_xepidemiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoadjuvant Therapy
_xstatistics & numerical data
650 0 4 _aPrevalence
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Analysis
650 0 4 _aSurvival Rate
650 0 4 _aTreatment Outcome
700 1 _aBuyevich, Victor
700 1 _aMachlenkin, Svetlana
700 1 _aZiv-Sokolovsky, Nadya
700 1 _aDinerman, Michael
700 1 _aBrenner, Baruch
700 1 _aKashtan, Hanoch
773 0 _tOnkologie
_gvol. 31
_gno. 12
_gp. 673-7
856 4 0 _uhttps://doi.org/10.1159/000165056
_zAvailable from publisher's website
999 _c18514566
_d18514566